MTOR and kidney angiomyolipoma: Renal angiomyolipomas associated with TSC or sporadic LAM (sLAM) exhibit upregulated activity of mammalian target of rapamycin (mTOR) resulting from mutations in either TSC1 or TSC2 genes [4,14].